Abu Dhabi Stem Cells Center to Begin Phase I/II Trial of Game-Changing Multiple Sclerosis Treatment

Abu Dhabi Stem Cells Center will begin the recruitment and enrollment of 45 patients in the Phase I/II study to evaluate the safety and efficacy of a pioneering new technology, Extracorporeal Photopheresis, which will be used in the treatment of multiple sclerosis.